"Biomarkers, Tumor" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS.
| Descriptor ID |
D014408
|
| MeSH Number(s) |
D23.101.140
|
| Concept/Terms |
Biomarkers, Tumor- Biomarkers, Tumor
- Tumor Biomarkers
- Markers, Biological Tumor
- Tumor Markers, Biological
- Markers, Tumor Metabolite
- Tumor Metabolite Markers
- Metabolite Markers, Tumor
- Marker, Tumor Metabolite
- Metabolite Marker, Tumor
- Tumor Metabolite Marker
- Tumor Markers, Biologic
- Biologic Tumor Markers
- Markers, Biologic Tumor
- Marker, Biologic Tumor
- Biologic Tumor Marker
- Tumor Marker, Biologic
- Biochemical Tumor Markers
- Markers, Biochemical Tumor
- Marker, Biochemical Tumor
- Biochemical Tumor Marker
- Tumor Marker, Biochemical
- Tumor Markers, Biochemical
- Carcinogen Markers
- Markers, Carcinogen
- Markers, Neoplasm Metabolite
- Neoplasm Metabolite Markers
- Marker, Neoplasm Metabolite
- Metabolite Marker, Neoplasm
- Neoplasm Metabolite Marker
- Metabolite Markers, Neoplasm
- Biological Tumor Markers
- Biological Tumor Marker
- Tumor Marker, Biological
- Marker, Biological Tumor
Markers, Tumor- Markers, Tumor
- Tumor Markers
- Biomarkers, Cancer
- Cancer Biomarkers
|
Below are MeSH descriptors whose meaning is more general than "Biomarkers, Tumor".
Below are MeSH descriptors whose meaning is more specific than "Biomarkers, Tumor".
This graph shows the total number of publications written about "Biomarkers, Tumor" by people in this website by year, and whether "Biomarkers, Tumor" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 2 | 3 |
| 1997 | 3 | 7 | 10 |
| 1998 | 2 | 4 | 6 |
| 1999 | 2 | 8 | 10 |
| 2000 | 2 | 11 | 13 |
| 2001 | 3 | 11 | 14 |
| 2002 | 8 | 5 | 13 |
| 2003 | 6 | 11 | 17 |
| 2004 | 12 | 14 | 26 |
| 2005 | 13 | 10 | 23 |
| 2006 | 16 | 13 | 29 |
| 2007 | 13 | 15 | 28 |
| 2008 | 23 | 18 | 41 |
| 2009 | 21 | 25 | 46 |
| 2010 | 14 | 19 | 33 |
| 2011 | 26 | 29 | 55 |
| 2012 | 29 | 18 | 47 |
| 2013 | 29 | 30 | 59 |
| 2014 | 17 | 24 | 41 |
| 2015 | 31 | 32 | 63 |
| 2016 | 24 | 35 | 59 |
| 2017 | 31 | 29 | 60 |
| 2018 | 32 | 35 | 67 |
| 2019 | 50 | 34 | 84 |
| 2020 | 44 | 27 | 71 |
| 2021 | 28 | 36 | 64 |
| 2022 | 2 | 28 | 30 |
| 2023 | 1 | 20 | 21 |
| 2024 | 21 | 39 | 60 |
| 2025 | 22 | 14 | 36 |
To return to the timeline,
click here.
Below are the most recent publications written about "Biomarkers, Tumor" by people in Profiles.
-
Papillary renal cell carcinoma, formerly known as Type 2: a single institutional study addressing histologic and molecular features. Histopathology. 2026 Apr; 88(5):1044-1050.
-
ROSIE: AI generation of multiplex immunofluorescence staining from histopathology images. Nat Commun. 2025 Aug 16; 16(1):7633.
-
Building digital histology models of transcriptional tumor programs with generative deep learning for pathology-based precision medicine. Genome Med. 2025 Aug 07; 17(1):87.
-
Early Dynamics of Circulating Tumor HPV-DNA with Neoadjuvant Chemotherapy and Response-Adapted De-escalation in Human Papillomavirus-Associated Oropharyngeal Cancer. Clin Cancer Res. 2025 Aug 01; 31(15):3150-3159.
-
Tumor-intrinsic and immune-related features associated with treatment failure in human papillomavirus-related oropharyngeal cancer. J Natl Cancer Inst. 2025 Jul 01; 117(7):1366-1376.
-
Tumor aneuploidy as a prognostic and predictive biomarker in immune checkpoint blockade. Nat Genet. 2025 Aug; 57(8):1802-1811.
-
Renal Tumorigenesis via RAS/RAF/MAPK Pathway Alterations Beyond Papillary Renal Neoplasm With Reverse Polarity. Am J Surg Pathol. 2025 Dec 01; 49(12):1266-1278.
-
A Proteogenomic View of Synchronous Endometrioid Endometrial and Ovarian Cancer. Clin Cancer Res. 2025 Jun 03; 31(11):2230-2240.
-
Development and validation of the Immune Profile Score (IPS), a novel multiomic algorithmic assay for stratifying outcomes in a real-world cohort of patients with advanced solid cancer treated with immune checkpoint inhibitors. J Immunother Cancer. 2025 May 30; 13(5).
-
Safety and Sample Adequacy for Comprehensive Biomarker Testing of Bronchoscopic Biopsies: An American Association of Bronchology and Interventional Pulmonology and International Association for the Study of Lung Cancer Clinical Practice Guideline. J Thorac Oncol. 2025 Sep; 20(9):1237-1256.